Isis Pharmaceuticals News
Isis Pharmaceuticals' Management Presents at UBS Global Healthcare Conference (Transcript)
Seeking Alpha May 20Isis Pharmaceuticals' Management Presents at UBS Global Healthcare Conference (Transcript)
ISIS Pharmaceuticals Management Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)
Seeking Alpha May 15ISIS Pharmaceuticals Management Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)
Sanofi/REGN Commence Enrollment - Analyst Blog
Zacks May 15Sanofi and Regeneron Pharma announced that they started enrolling patients for two phase III trials
Celgene Attains 52-Week High
May 14Isis Gets $3.5M Milestone Payment - Analyst Blog
Zacks May 14Isis Pharma announced that it has received a milestone payment of $3.5 million from Biogen
Celgene Attains 52-Week High - Analyst Blog
Zacks May 14Shares of Celgene hit a 52-week high of $131.13 on May 13.
Isis Pharmaceuticals to Present at the 2013 UBS Global Healthcare Conference
PR Newswire May 13CARLSBAD, Calif., May 13, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the 2013 ...
1 Biotech's Surprise Dilution Decoded
Fool May 12Isis Pharmaceuticals gives biotech investors a painful reminder that dilution can come when they least expect it.
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ISIS | 20.46 | -0.20 | -0.97% | 2.101B |
